Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Emphasizes “Deregulatory” Efforts In Mobile Medical Apps Final Guidance

This article was originally published in The Gray Sheet

Executive Summary

In a long-awaited final guidance, FDA affirmed its plan to practice enforcement discretion for most mobile medical apps, except those applications that present the same risks as conventional FDA-regulated devices. Some digital health stakeholders praised the guidance, while others wished FDA has waited.


Related Content

Get 'HIP'AA To Digital Medtech Law: More Than Just FDA To Worry About
Optometrists Group Says FDA Should Regulate Online Eye-Test Provider
Optometrists Say FDA Should Regulate Online Eye-Test Provider
Podcast: CEO Advises Digital Health Companies To Get Regulatory Help
Tips To App Developers: Know Your Agencies, Regulations
Podcast: Patel Cautions Against "Unintended Consequences" of mHealth Legislation
Pending Mobile Medical Apps Guidance Provokes Heated Controversy
Workgroup Unveils Preliminary Health IT Regulation Proposals
FDA Mobile Health Policy Proposal Draws Fire From Far And Wide
Industry Applauds FDA Draft Guidance On Mobile Medical Apps





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts